Prp8 intein in fungal pathogens: target for potential antifungal drugs

Xiang-Qin Liu1, Jing Yang

  • 1Department of Biochemistry and Molecular Biology, Dalhousie University, Halifax, NS, Canada B3H 4H7. pxqliu@dal.ca

FEBS Letters
|August 12, 2004
PubMed

Insights

Inteins within fungal pathogens like Aspergillus and Cryptococcus are identified as potential drug targets. These self-splicing protein sequences in the essential Prp8 protein can be targeted for new antifungal therapies.

Area of Science:

  • Molecular Biology
  • Mycology
  • Drug Discovery

Background:

  • Inteins are protein sequences that catalyze their own removal (splicing).
  • Inteins in pathogenic organisms represent potential targets for antimicrobial drug development.
  • The Prp8 protein is essential and highly conserved across many organisms.

Purpose of the Study:

  • To identify and characterize inteins in key fungal pathogens.
  • To investigate the potential of these inteins as antifungal drug targets.

Main Methods:

  • Bioinformatic analysis to identify inteins in fungal genomes.
  • Recombinant protein expression in Escherichia coli to demonstrate intein splicing activity.
  • Comparative analysis of intein size and domain composition.

Main Results:

  • Inteins were identified within the essential Prp8 protein of Aspergillus fumigatus, Aspergillus nidulans, Histoplasma capsulatum, and Cryptococcus neoformans.
  • Prp8 intein size varied significantly (170–819 amino acids) due to differences in endonuclease and tongs subdomain presence.
  • Demonstrated protein splicing activity of these fungal Prp8 inteins in a heterologous bacterial system.

Conclusions:

  • Fungal Prp8 inteins are viable targets for antifungal drug discovery.
  • The variability in intein structure offers opportunities for targeted drug design.
  • Existing screening and selection methods can be applied to identify drugs targeting these inteins.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...